Christopher Mark Smales (Christopher M Smales, C Mark Smales, C Mark Smales, C M Smales)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Topics

Monoclonal Antibody

Endoplasmic Reticulum

Top Venues

Biotechnology journal

Biotechnology and bioengineering

Biotechnology letters

This page only lists publications with an associated author ORCID identifier.

Publications

Eleftheria Skrika-Alexopoulos, Christopher Mark Smales
Isolation and characterisation of exosomes from Chinese hamster ovary (CHO) cells. Biotechnology letters 45 (4) (2023)
Eleftheria Skrika-Alexopoulos, Christopher Mark Smales
Isolation and characterisation of exosomes from Chinese hamster ovary (CHO) cells. Biotechnology letters (2023)
Thomas E Mulroney, Tuija Pöyry, Juan Carlos Yam-Puc, Maria Rust, Robert F Harvey, Lajos Kalmar, Emily C Horner, Lucy Booth, Alexander P Ferreira, Mark Stoneley, Ritwick Sawarkar, Alexander J Mentzer, Kathryn S Lilley, Christopher Mark Smales, Tobias von der Haar, Lance Turtle, Susanna J Dunachie, Paul Klenerman, James E D Thaventhiran, Anne E Willis
N 1 -methylpseudouridylation of mRNA causes +1 ribosomal frameshifting. Nature (2023)
Elizabeth Edwards, Maria Livanos, Anja Krueger, Anne Dell, Stuart M Haslam, Christopher Mark Smales, Daniel G Bracewell
Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation. Biotechnology and bioengineering 119 (6) (2022)
Fabio Hedayioglu, Emma J Mead, Patrick B F O'Connor, Matas Skiotys, Owen James Sansom, Giovanna R Mallucci, Anne E Willis, Pavel V Baranov, Christopher Mark Smales, Tobias von der Haar
Evaluating data integrity in ribosome footprinting datasets through modelled polysome profiles. Nucleic acids research 50 (19) (2022)
Tanya J Knight, Jane F Povey, Davide Vito, Atul Mohindra, Colin M Jaques, Christopher Mark Smales
Manipulation of mRNA translation elongation influences the fragmentation of a biotherapeutic Fc-fusion protein produced in CHO cells. Biotechnology and bioengineering 119 (12) (2022)
Laura E Dyball, Christopher Mark Smales
Exosomes: Biogenesis, targeting, characterization and their potential as "Plug & Play" vaccine platforms. Biotechnology journal 17 (11) (2022)
Hirra Hussain, Tulshi Patel, Angelica M S Ozanne, Davide Vito, Mark Ellis, Matthew Hinchliffe, David P Humphreys, Paul E Stephens, Bernie Sweeney, James White, Alan J Dickson, Christopher Mark Smales
A comparative analysis of recombinant Fab and full-length antibody production in Chinese hamster ovary cells. Biotechnology and bioengineering 118 (12) (2021)
Stuart P De Poi, Jianling Xie, Christopher Mark Smales, Christopher G Proud
Constitutively active Rheb mutants [T23M] and [E40K] drive increased production and secretion of recombinant protein in Chinese hamster ovary cells. Biotechnology and bioengineering 118 (7) (2021)
Jane F Povey, Emily Saintas, Adewale V Aderemi, Florian Rothweiler, Richard Zehner, Wilhelm G Dirks, Jindrich Cinatl, Andrew J Racher, Mark N Wass, Christopher Mark Smales, Martin Michaelis
Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines. Cells 8 (10) (2019)
Natalie E Talbot, Emma J Mead, Stephanie A Davies, Shahid Uddin, Christopher Mark Smales
Application of ER Stress Biomarkers to Predict Formulated Monoclonal Antibody Stability. Biotechnology journal 14 (10) (2019)
Eva Pekle, Andrew Smith, Guglielmo Rosignoli, Christopher Sellick, Christopher Mark Smales, Claire Pearce
Application of Imaging Flow Cytometry for the Characterization of Intracellular Attributes in Chinese Hamster Ovary Cell Lines at the Single-Cell Level. Biotechnology journal 14 (7) (2019)
Linas Tamošaitis, Christopher Mark Smales
Meta-Analysis of Publicly Available Chinese Hamster Ovary (CHO) Cell Transcriptomic Datasets for Identifying Engineering Targets to Enhance Recombinant Protein Yields. Biotechnology journal 13 (10) (2018)
Davide Vito, Christopher Mark Smales
The Long Non-Coding RNA Transcriptome Landscape in CHO Cells Under Batch and Fed-Batch Conditions. Biotechnology journal 13 (10) (2018)
Lyne Jossé, Lin Zhang, Christopher Mark Smales
Application of microRNA Targeted 3'UTRs to Repress DHFR Selection Marker Expression for Development of Recombinant Antibody Expressing CHO Cell Pools. Biotechnology journal 13 (10) (2018)
Aline G Almeida, Rodrigo C V Pinto, Christopher Mark Smales, Leda R Castilho
Investigations into, and development of, a lyophilized and formulated recombinant human factor IX produced from CHO cells. Biotechnology letters 39 (8) (2017)
Evdoxia Gourbatsi, Jane F Povey, Christopher Mark Smales
The effect of formulation variables on protein stability and integrity of a model IgG4 monoclonal antibody and translation to formulation of a model ScFv. Biotechnology letters 40 (1) (2017)